CN105328203B - 1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof - Google Patents
1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof Download PDFInfo
- Publication number
- CN105328203B CN105328203B CN201510622104.0A CN201510622104A CN105328203B CN 105328203 B CN105328203 B CN 105328203B CN 201510622104 A CN201510622104 A CN 201510622104A CN 105328203 B CN105328203 B CN 105328203B
- Authority
- CN
- China
- Prior art keywords
- serum albumin
- bovine serum
- triazole
- preparation
- mercaptan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940098773 bovine serum albumin Drugs 0.000 title claims abstract description 25
- 239000000463 material Substances 0.000 title claims abstract description 22
- 108091003079 Bovine Serum Albumin Proteins 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 150000000178 1,2,4-triazoles Chemical class 0.000 title 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 title 1
- 239000010931 gold Substances 0.000 claims abstract description 64
- 229910052737 gold Inorganic materials 0.000 claims abstract description 64
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 43
- AFBBKYQYNPNMAT-UHFFFAOYSA-N 1h-1,2,4-triazol-1-ium-3-thiolate Chemical compound SC=1N=CNN=1 AFBBKYQYNPNMAT-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000243 solution Substances 0.000 claims description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 230000005284 excitation Effects 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002371 ultraviolet--visible spectrum Methods 0.000 claims description 3
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 claims 1
- MLRAJZNPKPVUDQ-UHFFFAOYSA-N 3-sulfanyl-1,2-dihydrotriazole Chemical compound SN1NNC=C1 MLRAJZNPKPVUDQ-UHFFFAOYSA-N 0.000 claims 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 241000220317 Rosa Species 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 229910021505 gold(III) hydroxide Inorganic materials 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 235000011121 sodium hydroxide Nutrition 0.000 claims 1
- 239000012888 bovine serum Substances 0.000 abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- SJUCACGNNJFHLB-UHFFFAOYSA-N O=C1N[ClH](=O)NC2=C1NC(=O)N2 Chemical compound O=C1N[ClH](=O)NC2=C1NC(=O)N2 SJUCACGNNJFHLB-UHFFFAOYSA-N 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 description 13
- 239000002086 nanomaterial Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 239000003638 chemical reducing agent Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 4
- 239000003607 modifier Substances 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000005287 template synthesis Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/188—Metal complexes of other metals not provided for in one of the previous groups
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开一种1‑H‑1,2,4‑三氮唑‑3‑硫醇‑牛血清白蛋白‑金纳米团簇荧光材料及其制备方法,以氯金酸、1‑H‑1,2,4‑三氮唑‑3‑硫醇、牛血清白蛋白为原料一步合成水溶性金纳米团簇荧光材料。本发明是一种新型金纳米团簇荧光材料的制备方法,具有制备快速、简单、环保等优点。所合成的1‑H‑1,2,4‑三氮唑‑3‑硫醇‑牛血清白蛋白‑金纳米团簇显示出强烈的玫红色荧光(最大发射波长为650 nm),斯托克斯位移大(245 nm),水溶性好,具有较高的稳定性等优点。
The invention discloses a 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nano-cluster fluorescent material and a preparation method thereof. Chlorauric acid, 1-H-1 , 2,4‑triazole‑3‑thiol and bovine serum albumin were used as raw materials to synthesize water-soluble gold nanocluster fluorescent materials in one step. The invention is a preparation method of a novel gold nano-cluster fluorescent material, which has the advantages of rapid preparation, simplicity, environmental protection and the like. The synthesized 1‑H‑1,2,4‑triazole‑3‑thiol‑bovine serum albumin‑gold nanoclusters exhibit strong rose-red fluorescence (the maximum emission wavelength is 650 nm), Stoke It has the advantages of large Stein shift (245 nm), good water solubility and high stability.
Description
技术领域technical field
本发明涉及1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇荧光材料的制备方法,属于纳米技术领域。The invention relates to a preparation method of 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nano-cluster fluorescent material, which belongs to the field of nanotechnology.
背景技术Background technique
近年来,荧光纳米材料作为荧光标记物在生物学中的应用备受关注。目前为止,研究人员已经开发出了半导体量子点、染料掺杂纳米粒子、碳纳米点等多种不同类型的荧光纳米材料。荧光金纳米团簇(gold nanoclusters, AuNCs)作为一类新型的荧光纳米材料,具有光物理性质好、比表面积大、表面易于修饰以及荧光性质可调等优点。金纳米团簇是由几个至几十个金原子组成的稳定聚集体,直径通常小于2 nm,介于单原子和纳米粒子或大体积的金属之间。由于其尺寸接近于电子的费米波长,连续的能态性质分裂为离散的能态,并出现类似分子的尺寸依赖效应。在化合物检测、生物传感与成像、光电子学和纳米医学等领域有着广泛的应用前景。In recent years, the application of fluorescent nanomaterials as fluorescent markers in biology has attracted much attention. So far, researchers have developed many different types of fluorescent nanomaterials such as semiconductor quantum dots, dye-doped nanoparticles, and carbon nanodots. As a new class of fluorescent nanomaterials, fluorescent gold nanoclusters (AuNCs) have the advantages of good photophysical properties, large specific surface area, easy surface modification, and adjustable fluorescence properties. Gold nanoclusters are stable aggregates composed of several to dozens of gold atoms, usually less than 2 nm in diameter, between single atoms and nanoparticles or bulky metals. Due to its size close to the Fermi wavelength of electrons, the continuous energy state property splits into discrete energy states, and molecular-like size-dependent effects appear. It has broad application prospects in the fields of compound detection, biosensing and imaging, optoelectronics and nanomedicine.
金纳米团簇荧光材料的制备技术主要包括化学还原法、反相微乳液法、模板合成法单分子层保护技术和配体蚀刻法等。其中单分子层保护技术是一种简易温和的团簇合成方法,利用含一定官能团的小分子作为保护基,在团簇表面形成保护层,从而稳定金纳米团簇,使其不易团聚。近几十年来,国内外的研究者们提出了多种不同的方法制备高荧光量子产率、水溶性好、发光颜色可调的金纳米团簇。The preparation techniques of gold nanocluster fluorescent materials mainly include chemical reduction method, inverse microemulsion method, template synthesis method, monomolecular layer protection technology and ligand etching method. Among them, the monolayer protection technology is a simple and gentle cluster synthesis method. Small molecules containing certain functional groups are used as protective groups to form a protective layer on the cluster surface, thereby stabilizing gold nanoclusters and making them difficult to agglomerate. In recent decades, researchers at home and abroad have proposed a variety of different methods to prepare gold nanoclusters with high fluorescence quantum yield, good water solubility and tunable emission color.
本发明以氯金酸、1-H-1,2,4-三氮唑-3-硫醇、牛血清白蛋白为原料一步合成水溶性金纳米团簇荧光材料。牛血清白蛋白作为稳定剂,1-H-1,2,4-三氮唑-3-硫醇为还原剂和修饰剂控制金纳米团簇的形成。所制备出的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇具有强烈的玫红色荧光,斯托克斯位移大,水溶性好。The invention uses chloroauric acid, 1-H-1,2,4-triazole-3-thiol and bovine serum albumin as raw materials to synthesize the water-soluble gold nano-cluster fluorescent material in one step. Bovine serum albumin was used as a stabilizer, and 1-H-1,2,4-triazole-3-thiol was used as a reducing agent and modifier to control the formation of gold nanoclusters. The prepared 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster has strong rose-red fluorescence, large Stokes shift and good water solubility.
发明内容Contents of the invention
本发明的目的是提供一种1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇荧光材料及其以1-H-1,2,4-三氮唑-3-硫醇为还原剂和修饰剂,以牛血清白蛋白为稳定剂一步合成金纳米团簇荧光材料的方法。The object of the present invention is to provide a kind of 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nano-cluster fluorescent material and its 1-H-1,2,4 - Triazole-3-thiol is a reducing agent and a modifier, and bovine serum albumin is used as a stabilizer to synthesize a gold nano-cluster fluorescent material in one step.
为了实现上述目的,本发明采用以下技术方案:本发明所述的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇荧光材料的制备方法,其特征是它由以下步骤制成:牛血清白蛋白溶液与氯金酸溶液混合均匀,然后加入1-H-1,2,4-三氮唑-3-硫醇溶液,振摇混匀,反应一定时间得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇,金纳米团簇荧光材料水溶液冷冻干燥后可得到金纳米团簇荧光材料粉末。In order to achieve the above object, the present invention adopts the following technical solutions: the preparation method of 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster fluorescent material of the present invention , which is characterized in that it is made by the following steps: mixing bovine serum albumin solution and chloroauric acid solution evenly, then adding 1-H-1,2,4-triazole-3-thiol solution, shaking and mixing , react for a certain period of time to obtain 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanoclusters, gold nanoclusters can be obtained after freeze-drying the aqueous solution of the fluorescent material of the gold nanoclusters Fluorescent material powder.
所述的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇荧光材料的制备方法,其特征是以牛血清白蛋白作为稳定剂,1-H-1,2,4-三氮唑-3-硫醇为还原剂和修饰剂控制金纳米团簇的形成。The preparation method of the described 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster fluorescent material is characterized in that bovine serum albumin is used as a stabilizer, 1 -H-1,2,4-triazole-3-thiol was used as reducing agent and modifier to control the formation of gold nanoclusters.
所述的氯金酸溶液、牛血清白蛋白溶液和1-H-1,2,4-三氮唑-3-硫醇溶液的体积比为5:3:2。The volume ratio of the chloroauric acid solution, bovine serum albumin solution and 1-H-1,2,4-triazole-3-thiol solution is 5:3:2.
所用的氯金酸溶液的浓度可以是1~100 mmol/L,最优选浓度为10 mmol/L,牛血清白蛋白溶液可以是5~500 mg/mL,最优选浓度为50 mg/mL,1-H-1,2,4-三氮唑-3-硫醇溶液的浓度可以是0.01~1 mol/L,最优选浓度为 0.1 mol/L,其中溶解有最优选浓度为0.1mol/L的氢氧化钠。The concentration of the chloroauric acid solution used can be 1~100 mmol/L, the most preferred concentration is 10 mmol/L, the bovine serum albumin solution can be 5~500 mg/mL, the most preferred concentration is 50 mg/mL, 1 The concentration of -H-1,2,4-triazole-3-thiol solution can be 0.01~1 mol/L, the most preferred concentration is 0.1 mol/L, and the most preferred concentration is 0.1 mol/L dissolved therein sodium hydroxide.
所述氯金酸溶液、牛血清白蛋白溶液与1-H-1,2,4-三氮唑-3-硫醇溶液混匀后置于4℃反应0.5~2 小时,最优选1 h。The chloroauric acid solution, the bovine serum albumin solution and the 1-H-1,2,4-triazole-3-thiol solution were mixed evenly and then placed at 4°C for 0.5-2 hours, most preferably 1 hour.
所制得的金纳米团簇材料水溶液为无色,紫外可见光谱在520 nm处无吸收峰。在紫外灯照射下产生强烈的玫红色荧光,最大激发波长和发射波长分别为405 nm和650 nm。The prepared gold nanocluster material aqueous solution is colorless, and has no absorption peak at 520 nm in the ultraviolet-visible spectrum. Under the irradiation of ultraviolet light, it produces strong rose-red fluorescence, and the maximum excitation wavelength and emission wavelength are 405 nm and 650 nm, respectively.
本发明最佳的金纳米团簇荧光材料的制备方法如下:The preparation method of the best gold nanocluster fluorescent material of the present invention is as follows:
以下过程中使用的所有玻璃器皿均经过王水浸泡,并用双蒸水彻底清洗,晾干。金纳米团簇荧光材料的制备如下:0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得的金纳米团簇为红棕色的液体,紫外灯(365 nm)照射下有强烈玫红色荧光。All glassware used in the following procedure was soaked in aqua regia, rinsed thoroughly with double distilled water, and allowed to dry. The gold nanocluster fluorescent material was prepared as follows: 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL was mixed with 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and 0.5 mL of 0.1 mol/L 1-H-1,2,4-triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, react at 4°C for 1 h to obtain 1-H-1,2 , 4-triazole-3-thiol-bovine serum albumin-gold nanoclusters. The obtained gold nanoclusters are reddish-brown liquid with strong rose-red fluorescence under the irradiation of ultraviolet lamp (365 nm).
本发明上述的制备方法制得的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇,其特征是易溶于水,水溶液为红棕色,在紫外灯照射下产生强烈的玫红色荧光,最大激发波长和发射波长分别为405 nm和650 nm。The 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster prepared by the above-mentioned preparation method of the present invention is characterized in that it is easily soluble in water, and the aqueous solution is reddish brown , produces strong rose-red fluorescence under ultraviolet light irradiation, and the maximum excitation and emission wavelengths are 405 nm and 650 nm, respectively.
所述金纳米团簇平均粒径为2 nm。The average particle size of the gold nanoclusters is 2 nm.
所述的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇,其特征是水溶液在4 ℃暗处下放置2个月无沉降物出现,荧光强度及最大发射峰位置保持不变。The 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster is characterized in that the aqueous solution is placed in the dark at 4°C for 2 months without sedimentation , the fluorescence intensity and the position of the maximum emission peak remained unchanged.
所述的1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇,其特征是以氯金酸为金源,1-H-1,2,4-三氮唑-3-硫醇为还原剂和修饰剂,牛血清白蛋白为稳定剂制备。The 1-H-1,2,4-triazole-3-thiol-bovine serum albumin-gold nanocluster is characterized in that chloroauric acid is the gold source, 1-H-1,2 , 4-triazole-3-thiol is used as a reducing agent and a modifying agent, and bovine serum albumin is used as a stabilizer.
本发明的优点:Advantages of the present invention:
(1)本发明以1-H-1,2,4-三氮唑-3-硫醇为还原剂和修饰剂,在牛血清白蛋白存在的条件下一步合成水溶性金纳米团簇荧光材料,具有制备快速、简单、环保的优点。(1) In the present invention, 1-H-1,2,4-triazole-3-thiol is used as a reducing agent and a modifier, and a water-soluble gold nanocluster fluorescent material is synthesized in the next step in the presence of bovine serum albumin , which has the advantages of fast, simple and environmentally friendly preparation.
(2)本发明所制备的金纳米团簇具有强烈的玫红色荧光(最大发射波长为650nm),较大的斯托克斯位移(245 nm)等特点。(2) The gold nanoclusters prepared by the present invention have strong rose-red fluorescence (maximum emission wavelength is 650 nm), large Stokes shift (245 nm) and other characteristics.
附图说明Description of drawings
图1为金纳米团簇荧光纳米材料在可见光(A)和紫外灯下(B)的外观图。Figure 1 shows the appearance of gold nanocluster fluorescent nanomaterials under visible light (A) and ultraviolet light (B).
图2为金纳米团簇荧光纳米材料的紫外-可见吸收光谱图。Fig. 2 is an ultraviolet-visible absorption spectrum diagram of a gold nanocluster fluorescent nanomaterial.
图3为金纳米团簇荧光纳米材料的激发和发射光谱图。Fig. 3 is the excitation and emission spectrum diagram of the gold nanocluster fluorescent nanomaterial.
图4为金纳米团簇荧光纳米材料的能量散射X射线能谱图。Fig. 4 is an energy-scattering X-ray energy spectrum diagram of a fluorescent nanomaterial of a gold nanocluster.
图5为金纳米团簇荧光纳米材料的透射电镜图。Fig. 5 is a transmission electron microscope image of a gold nanocluster fluorescent nanomaterial.
图6为金纳米团簇荧光纳米材料的X射线光电子能谱图。Fig. 6 is an X-ray photoelectron energy spectrum diagram of a gold nanocluster fluorescent nanomaterial.
具体实施方式Detailed ways
实例1:Example 1:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得的金纳米团簇为红棕色的液体(见图1A),紫外灯照射下产生强烈的玫红色荧光(见图1B)。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The obtained gold nanoclusters are a reddish-brown liquid (see Figure 1A), which produces strong rose-red fluorescence under ultraviolet light (see Figure 1B).
实例2:Example 2:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得到的金纳米团簇溶液进行紫外-可见光谱扫描,得其在520 nm波长处无金纳米粒子特征吸收峰(见图2)。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The obtained gold nanocluster solution was scanned by ultraviolet-visible spectrum, and it was found that it had no characteristic absorption peak of gold nanoparticles at a wavelength of 520 nm (see FIG. 2 ).
实例3:Example 3:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得到的金纳米团簇溶液进行荧光光谱扫描,得其最大激发波长和发射波长分别为405 nm和650 nm(见图3)。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The obtained gold nanocluster solution was scanned by fluorescence spectrum, and its maximum excitation wavelength and emission wavelength were 405 nm and 650 nm, respectively (see Figure 3).
实例4:Example 4:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得到的金纳米团簇溶液滴涂在铜网上。能量散射X射线能谱分析(见图4)表明产物含有金元素。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The resulting gold nanocluster solution was drop-coated on a copper grid. Energy dispersive X-ray spectroscopy (see Figure 4) showed that the product contained gold.
实例5:Example 5:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得到的金纳米团簇溶液进行透射电镜的测定,测得金纳米团簇的平均粒径为2nm(见图5)。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The obtained gold nanocluster solution was measured by a transmission electron microscope, and the average particle size of the gold nanocluster was measured to be 2 nm (see FIG. 5 ).
实例6:Example 6:
0.75 mL浓度为50 mg/mL的牛血清白蛋白与1.25 mL浓度为10 mmol/L的氯金酸溶液混合均匀,加入0.5 mL浓度为0.1 mol/L的1-H-1,2,4-三氮唑-3-硫醇溶液(含0.1 mol/L氢氧化钠),振摇混匀,4℃下反应1 h,得到1-H-1,2,4-三氮唑-3-硫醇-牛血清白蛋白-金纳米团簇。所得到的金纳米团簇溶液冷冻干燥后得到粉末,取所得粉末进行X射线光电子能谱测定,XPS Au(4f)显示金的4f7/2峰与4f5/2峰分别位于84.5 eV和88.2 eV,表明金纳米团簇中金的价态以0价和+1价方式共存(见图6)。Mix 0.75 mL of bovine serum albumin with a concentration of 50 mg/mL and 1.25 mL of chloroauric acid solution with a concentration of 10 mmol/L, and add 0.5 mL of 1-H-1,2,4- Triazole-3-thiol solution (containing 0.1 mol/L sodium hydroxide), shake and mix well, and react at 4°C for 1 h to obtain 1-H-1,2,4-triazole-3-thiol Alcohol-Bovine Serum Albumin-Gold Nanoclusters. The obtained gold nanocluster solution was freeze-dried to obtain a powder, and the obtained powder was measured by X-ray photoelectron spectroscopy. XPS Au(4f) showed that the gold 4f 7/2 peak and 4f 5/2 peak were located at 84.5 eV and 88.2 eV, respectively. eV, indicating that the valence states of gold in gold nanoclusters coexist in 0-valence and +1-valence modes (see Figure 6).
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510622104.0A CN105328203B (en) | 2015-09-26 | 2015-09-26 | 1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510622104.0A CN105328203B (en) | 2015-09-26 | 2015-09-26 | 1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105328203A CN105328203A (en) | 2016-02-17 |
CN105328203B true CN105328203B (en) | 2018-04-17 |
Family
ID=55279079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510622104.0A Expired - Fee Related CN105328203B (en) | 2015-09-26 | 2015-09-26 | 1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105328203B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105860963B (en) * | 2016-04-16 | 2018-06-22 | 福建医科大学 | Guanidine hydrochloride/6- azepines -2- thio-thymines-gold nano cluster and preparation method thereof |
CN105860959B (en) * | 2016-04-16 | 2018-05-18 | 福建医科大学 | Arginine/6- azepines -2- thio-thymines-gold nano cluster and preparation method thereof |
CN105689735B (en) * | 2016-04-20 | 2017-10-17 | 中国科学院新疆理化技术研究所 | A kind of preparation method and application of the gold nanoclusters of fluorescence and size adjustable |
CN106353290B (en) * | 2016-09-28 | 2019-03-26 | 西华师范大学 | The fluorescence gold nanoclusters synthetic method and lemon yellow measuring method of triazole package |
CN106984827B (en) * | 2017-03-08 | 2019-08-16 | 吉林大学 | It is a kind of using dithiothreitol (DTT) synthesis gold nano-material, preparation method and application |
CN110079299B (en) * | 2019-05-08 | 2022-01-04 | 桂林理工大学 | Preparation method of sulfur quantum dot coated bovine serum albumin fluorescent composite nanospheres |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876480A (en) * | 1996-02-20 | 1999-03-02 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of unagglomerated metal nano-particles at membrane interfaces |
CN101406961B (en) * | 2008-11-25 | 2011-06-22 | 哈尔滨工业大学 | Preparation method of water-soluble gold nanocluster |
US20120195833A1 (en) * | 2011-02-01 | 2012-08-02 | Chung Yuan Christian University | Medical Contrast Agent Made of Microbubbles Containing Fluorescent Gold Nanoclusters |
CN102838984B (en) * | 2012-09-12 | 2014-06-04 | 浙江理工大学 | Preparation method of chymotrypsin protected fluorescent au nanocluster material |
-
2015
- 2015-09-26 CN CN201510622104.0A patent/CN105328203B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN105328203A (en) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105199717B (en) | 2 mercaptoimidazole bovine serum albumin(BSA) fluorescent au nanocluster materials and preparation method thereof | |
CN105328203B (en) | 1 H, 1,2,4 triazoles, 3 mercaptan bovine serum albumin(BSA) fluorescent au nanocluster material and preparation method thereof | |
CN1795141B (en) | Manufacturing method and use of metal nanorods | |
WO2022032871A1 (en) | Infrared ii region fluorogold nanocluster, preparation and application thereof | |
CN105199716B (en) | 3 mercaptopropionic acid bovine serum albumin(BSA) gold nano clusters and preparation method thereof | |
CN105860959B (en) | Arginine/6- azepines -2- thio-thymines-gold nano cluster and preparation method thereof | |
CN107384386B (en) | A kind of synthesis method of perovskite CsPbX3 quantum wire | |
EP2830795B1 (en) | Nano aggregates of molecular ultra small clusters of noble metals and a process for the preparation thereof | |
CN105368447B (en) | 1‑methyl‑5‑mercaptotetrazolium‑bovine serum albumin‑gold nanocluster fluorescent material and preparation method thereof | |
CN102701265A (en) | Water-phase preparation method of near-infrared luminescent silver sulfide quantum dot | |
CN107603604B (en) | Copper nanocluster fluorescent material and preparation method thereof | |
CN105820809B (en) | 6 azepine, 2 thio-thymine gold nano cluster and preparation method thereof | |
Wadhwa et al. | Engineering of luminescent graphene quantum dot-gold (GQD-Au) hybrid nanoparticles for functional applications | |
CN103691968A (en) | Gold aggregate nano material with cubic structure and synthesis method thereof | |
CN110669506A (en) | Preparation method of water-soluble gold nanocluster fluorescent material co-protected by cysteamine and N-acetyl L-cysteine | |
CN101905328B (en) | A kind of preparation method of water-soluble Au10 nano-cluster molecule | |
JP5915529B2 (en) | Manufacturing method of semiconductor nanoparticle assembly | |
CN105238394B (en) | 3 mercaptopropionic acid human serum fluorescent au nanocluster materials and preparation method thereof | |
Sonsin et al. | Tuning the photoluminescence by engineering surface states/size of S, N co-doped carbon dots for cellular imaging applications | |
CN108949145A (en) | Urase-fluorescent au nanocluster material and preparation method thereof | |
Lv et al. | Self-produced bubble-template synthesis of La 2 O 3: Yb/Er@ Au hollow spheres with markedly enhanced luminescence and release properties | |
CN107032388A (en) | A kind of method that normal temperature and pressure prepares silver sulfide quantum dot | |
CN107584136A (en) | Carboxyl chitosan dithiothreitol (DTT) gold nano cluster and preparation method thereof | |
Brichkin et al. | Hydrophilic semiconductor quantum dots | |
JP5604835B2 (en) | Semiconductor nanoparticles and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180417 |